Makefield Therapeutics to patent applications covering its Hybrid Nanoparticle drug delivery platform (News-Medical-Net)

Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield’s biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.
(get the story…)

Related items

• Makefield Therapeutics gets licensed patent covering biodegradable Hybrid Nanoparticles (PharmaBiz)
• Nanoparticles-safe and effective treatment for erectile dysfunction (News-Medical-Net)
• Novel Nanotechnology Heals Abscesses Caused by Resistant Staph Bacteria (Newswise)
• Novel nanotechnology heals abscesses caused by resistant staph bacteria (EurekAlert!)
• Magnetic Nanoparticles Show Promise For Combating Human Cancer (Medical News Today)

Tags: albert einstein college, albert einstein college of medicine, albert einstein college of medicine of yeshiva university, company, einstein college of medicine, Inc, Makefield, medicin, medicine, nano, nanoparticle, nanoparticles, patent applications, Therapeutics, today

This entry was posted on Wednesday, December 16th, 2009 at 7:53 pm and is filed under Technology.